Friday, May 1, 2026

Trump Declares War Footing: “Pick A Side Now,” Says New U.S. Strategy Targeting China

Trump's upcoming National Defense Strategy may prioritize countering China over homeland defense, impacting U.S. response to North Korea.

CT-P55: How Celltrion’s New Biosimilar Approval Will Transform Clinical Trials in Europe

Celltrion receives EMA approval to reduce patient enrollment for CT-P55 trial, aiming to cut costs and duration of clinical development.

Samchundang Pharm Announces 250 Billion KRW Stake Sale…Expectations Rise for Future Growth

Samchundang Pharm's CEO plans a 2.5 billion KRW share sale for tax purposes, hinting at significant news and future growth in pharma.

Tag: private sector

No posts to display

Top News

- Our Sponsors Ad -

Follow us